Enzene Biosciences Limited - life sciences in Pune, Maharashtra, India. FY 2026 financials and compliance.
CIN U24232PN2006PLC165610 Incorporated 28 August 2006 ROC Pune HQ Pune, Maharashtra, India
Active Public Limited Company life sciences
Data last updated
Revenue · FY 2025
₹374.22 Cr
Latest filing
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹66 Cr
Registered with MCA
Paid-up capital
₹51.39 Cr
Issued & subscribed
Open charges
₹157.37 Cr
Satisfied ₹137.95 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
665
Latest available

About Enzene Biosciences Limited

Data last updated: 25 December 2025

Enzene Biosciences Limited is a public limited company based in Pune, Maharashtra, India, a subsidiary of Alkem Laboratories Limited. It specialises in biotechnology, a part of the broader life sciences sector. Incorporated on 28 August 2006, the company has been in operation for over 20 years.

Registered with ROC Pune under CIN U24232PN2006PLC165610.

Capital: an authorised share capital of ₹66 Cr and a paid-up capital of ₹51.39 Cr. Formerly known as Enzene Biosciences Private Limited. It is led by directors including Sudha Ravi and Aniruddha Singh.

Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No A 22 A/1/2 Chakan Industrial Area Phase 2 Khalumbre Chakan, Pune, Maharashtra, India – 410501.

As per the financials filed for FY 2025, the company reported a revenue of ₹374.22 Cr.

The company has a workforce of approximately 665 employees as per the latest available data. It operates as a subsidiary of Alkem Laboratories Limited.

The company is associated with 1 brand - Enzene Biosciences. As per MCA filings, the company has open charges of ₹157.37 Cr and satisfied charges of ₹137.95 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website enzene.com.

Company Details of Enzene Biosciences Limited
CIN U24232PN2006PLC165610
Registration Number 165610
Incorporation Date 28 August 2006
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 August 2025
Date of Balance Sheet 31 March 2025
Parent Company Alkem Laboratories Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Plot No A 22 A/1/2 Chakan Industrial Area Phase 2 Khalumbre Chakan, Pune, Maharashtra, India – 410501
  • Industry
    Life Sciences, Biotechnology
Company report
Enzene Biosciences Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Enzene Biosciences Limited report

Financials, compliance, directors, charges, ownership and filings for Enzene Biosciences Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Enzene Biosciences Limited

Enzene Biosciences Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232PN2006PLC165610, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24232PN2006PLC165610 Current
U24232KA2006PTC040295 Previous
U24232KA2006PLC040295 Previous

Associated Brands with Enzene Biosciences Limited

Enzene Biosciences Limited operates one associated brand: Enzene Biosciences. These brands represent Enzene Biosciences Limited's diversified market presence and brand portfolio.

Brand Description Website
Company specializing in development of Biosimilars enzene.com

Competitors & Alternatives of Enzene Biosciences Limited

Brands and companies operating in the same space as Enzene Biosciences Limited include Hybio Pharmaceutical, PolyPeptide, AmbioPharm and 6 more.

Competitor Description Location Founded
Hybio Pharmaceutical Hybio Pharmaceutical Polypeptide drugs and APIs are developed and manufactured. Shenzhen, China, China 1998
PolyPeptide PolyPeptide Proprietary, GMP-grade, and non-GMP peptides are manufactured by PolyPeptide Labs. Baar, Switzerland, Switzerland 1952
AmbioPharm AmbioPharm CDMO and analytical services for peptide development are provided. North Augusta, United States, United States 2006
vivitide vivitide Drug development services for neoantigen peptides and antibodies are provided. Gardner, United States, United States 1983
Shaanxi Micot Technology Shaanxi Micot Technology Drug R&D services for cardiovascular and metabolic diseases are provided. China 2007
Aperiam Bio Aperiam Bio Industrial and therapeutic proteins are manufactured by Aperiam Bio. United States 2019
Rameda Rameda Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products Giza, Egypt, Egypt 1994
Ocelot Bio Ocelot Bio Ocelot Bio is a CDMO specializing in peptide manufacturing services. San Diego, United States, United States 2020
Maruho Maruho Conducts R&D and manufactures ethical drugs for healthcare applications. Osaka, Japan, Japan 1915

Business Activity of Enzene Biosciences Limited

Enzene Biosciences Limited operates primarily in the manufacturing and professional, scientific and technical sectors. The company has 2 registered business activity segments, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Locked Professional, Scientific and Technical Locked Scientific research and development Locked
Premium access

Detailed business activity records for Enzene Biosciences Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Enzene Biosciences Limited

Enzene Biosciences Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2025. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Deloitte Haskins & Sells LLP Locked Locked Locked
Premium access

Complete auditor history for Enzene Biosciences Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Enzene Biosciences Limited

Enzene Biosciences Limited currently reports 6 directors and 1 key managerial person. 18 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Sudha Ravi Director 09 Feb 2017 9 Years 5 Months Current
Aniruddha Singh Additional Director 07 Mar 2025 1 Years 4 Months Current
Sangeeta Kapil Jit Singh Director 02 Aug 2022 3 Years 11 Months Current
Prem Venkatachalam Pavoor Director 30 Jan 2023 3 Years 5 Months Current
Himanshu Shashikant Gadgil Ceo 02 Feb 2022 4 Years 5 Months Current
Sandeep Singh Director 20 Oct 2011 14 Years 9 Months Current
Showing 6 of 7 current directors and KMP. View all directors and KMP

Financials of Enzene Biosciences Limited FY 2025 filings available

Enzene Biosciences Limited reported revenue of ₹374.22 Cr for FY 2025.

Revenue · FY 2025
₹374.22 Cr
Premium access

Ten-year financial statements for Enzene Biosciences Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Enzene Biosciences Limited

Premium access

Shareholding and ownership data for Enzene Biosciences Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Enzene Biosciences Limited

Open charges
₹157.37 Cr
Satisfied charges
₹137.95 Cr
Breakdown by lending institutions
Others₹80.00 Cr
Axis Bank Limited₹77.12 Cr
Hdfc Bank Limited₹0.25 Cr
Latest charge details
DateLenderAmountStatus
16 Feb 2024 Others ₹80 Cr Open
31 May 2018 Axis Bank Limited ₹77.12 Cr Open
28 Mar 2018 Hdfc Bank Limited ₹25 Lakh Open
16 Dec 2022 Others ₹43.75 Cr Satisfied
19 Apr 2017 Axis Bank Limited ₹45.14 Cr Satisfied

Total charge records: 8 View all charges

Employees and EPFO Compliance at Enzene Biosciences Limited

Enzene Biosciences Limited has a workforce of 665 employees as of Dec 25, 2025.

Employee count
665
Active EPFO establishments
2
Employee growth
11.39%
Premium access

Employee and EPFO history for Enzene Biosciences Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Enzene Biosciences Limited

Premium access

GST registrations and filing compliance for Enzene Biosciences Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Enzene Biosciences Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Enzene Biosciences Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Enzene Biosciences Limited

Premium access

MSME payment history for Enzene Biosciences Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Enzene Biosciences Limited

Premium access

Corporate group structure for Enzene Biosciences Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Enzene Biosciences Limited

Premium access

MCA filings and documents for Enzene Biosciences Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Enzene Biosciences Limited

Charges
18 Sep 2025
A charge registered on 16 Dec 2022 via Charge ID 100699653 with Others was fully satisfied on 18 Sep 2025.
Activity
22 Aug 2025
Enzene Biosciences Limited last Annual general meeting of members was held on 22 Aug 2025 as per latest MCA records.
Directors
14 Aug 2025
Vikas Gupta was appointed as a Additional Director on 14 Aug 2025 & has been associated with this company since 11 months 12 days.
Activity
31 Mar 2025
Enzene Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Directors
28 Mar 2025
Nilesh Ambani was appointed as a Cfo on 28 Mar 2025 & has been associated with this company since 1 year 4 months.
Directors
07 Mar 2025
Aniruddha Singh was appointed as a Additional Director on 07 Mar 2025 & has been associated with this company since 1 year 4 months.

Frequently Asked Questions about Enzene Biosciences Limited

Enzene Biosciences Limited is an active public limited company in the life sciences sector based in Pune, Maharashtra, India. It was incorporated on 28 August 2006 (20+ years old) and is registered under CIN U24232PN2006PLC165610. The company has 665 employees.

Enzene Biosciences Limited reported revenue of ₹374.22 Cr for FY 2025.

The current directors and KMP of Enzene Biosciences Limited are:

The primary industry of Enzene Biosciences Limited is life sciences. The company specifically operates in biotechnology. The company is currently active in this sector.

Enzene Biosciences Limited can be reached at the registered office: Plot No A 22 A12 Chakan Industrial Area Phase 2 Khalumbre Chakan, Pune, Maharashtra, India – 410501, or through the website enzene.com.

The authorised capital is ₹66 Cr, and the paid-up capital is ₹51.39 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available